BUZZ-AxoGen shares surge on optimistic annual revenue outlook

October 28 - ** Surgical instrument manufacturer AxoGen AXGN.O shares rose 30.3% to $48.79

** If the rally holds, the stock will record its largest single-day gain in more than two years

** The company expects full-year revenue of $290 million, higher than analysts' estimate of $283.2 million

** According to data compiled by London Stock Exchange Group (LSEG), AXGN's third-quarter revenue was $75.8 million, higher than analysts' expectation of $73.2 million

** Eleven brokerages covering the stock have a "buy" or higher rating; the median target price is $53, according to data compiled by London Stock Exchange Group (LSEG)

** Including today's gains, the stock has risen 42.5% year to date

(To facilitate non-native English speakers, Reuters automatically translates its reports into several other languages. Due to potential errors or lack of desired context in automated translations, Reuters does not guarantee the accuracy of the automated translation text. Automated translation is provided only for readers’ convenience. Reuters assumes no responsibility for any damage or loss arising from the use of the automated translation feature.)